PETER DONNAN: Open Payments
NPI 1477523371 · CORDELE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 36 payments from 15 companies in 2025. Trend: 2023 $535 · 2024 $549 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 10 | $206 |
| Medtronic, Inc. | 3 | $61 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Dexcom, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Lilly USA, LLC | 3 | $48 |
| Radius Health, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 1 | $28 |
Products named: LEQVIO, INTELLIS ADAPTIVESTIM, VOQUEZNA, Dexcom G6 Transmitter, REXULTI, MOUNJARO, Tymlos, JARDIANCE.
Industry payments across GA — which companies pay providers there.
